PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2020-12-09

Date Title Company
09-Dec-2020 Orgenesis signs joint venture with Cure Therapeutics to advance point-of-care development and commercialization of cell and gene therapies Orgenesis Inc
09-Dec-2020 Evelo Biosciences Announces New Clinical Candidate in Oncology and Presents Additional Interim Data from Phase 1/2 Clinical Trial of EDP1503 in Patients with Triple-Negative Breast Cancer Evelo Biosciences, Inc
09-Dec-2020 RxPONDER Study Results Demonstrate that the Oncotype DX® Test Can Now Spare Chemotherapy Use in the Majority of Women with Node-positive Early-stage Breast Cancer Exact Sciences Corp
09-Dec-2020 Evelo Biosciences Announces New Clinical Candidate in Oncology and Presents Additional Interim Data from Phase 1/2 Clinical Trial of EDP1503 in Patients with Triple-Negative Breast Cancer Evelo Biosciences, Inc
09-Dec-2020 Evelo Biosciences Reports Positive Topline Clinical Data in Phase 1b Trial of EDP1815 in Atopic Dermatitis Evelo Biosciences, Inc
09-Dec-2020 Clasado announces clinician-led gut health digital event for February 2021 Clasado
09-Dec-2020 Future Market Insights Provides Radio Frequency Beauty Equipment Market Projections in its Revised Report, COVID-19 Pandemic Shaping Global Demand MARKITWIRED
09-Dec-2020 North America Outbound Medical Tourism Services Market Players to Reset their Production Strategies Post 2020 in an Effort to Compensate for Heavy Loss Incurred Due to COVID-19 Outbreak MARKITWIRED
09-Dec-2020 Demand for Portable Oxygen Concentrators to Experience a Significant Dip in 2020, Influenced by COVID-19 Pandemic MARKITWIRED
09-Dec-2020 North America and Europe Dermal Filler Market Forecast Revised in a New Future Market Insights Report as COVID-19 Projected to Hold a Massive Impact on Sales in 2020 MARKITWIRED
09-Dec-2020 Original-Research: Paion AG (von First Berlin Equity Research GmbH) Paion AG
09-Dec-2020 RSLV-132 Demonstrates Clinically Meaningful Improvement in Patients With Systemic Lupus Erythematosus in Phase 2a Clinical Trial Newswire
09-Dec-2020 Late-Onset Sepsis Reduced in Premature Infants Fed Prolacta's 100% Human Milk-Based Fortifiers as Part of an Exclusive Human Milk Diet Prolacta Bioscience
09-Dec-2020 New Signatera(TM) Data to be Presented at the 2020 ESMO IO Congress from the Phase III IMvigor010 Trial Natera, Inc.
09-Dec-2020 RxPONDER Study Results Demonstrate that the Oncotype DX® Test Can Now Spare Chemotherapy Use in the Majority of Women with Node-positive Early-stage Breast Cancer EXACT SCIENCES CORP
09-Dec-2020 Advanced Testing Options Help Alter the Fight Against Cancer FinancialBuzz.com
09-Dec-2020 New Outcomes4Me Study Reveals Breast Cancer Patients Not Offered Genomic Testing Despite Ability to Save Lives Outcomes4Me Inc.
09-Dec-2020 Neurotrope, Inc. Completes Independent Spin-off of Neurotrope Bioscience, Inc. and is Renamed Synaptogenix, Inc. Neurotrope Bioscience, Inc.
09-Dec-2020 RxPONDER Study Results Demonstrate that the Oncotype DX® Test Can Now Spare Chemotherapy Use in the Majority of Women with Node-positive Early-stage Breast Cancer EXACT SCIENCES CORP
09-Dec-2020 Bolt Biotherapeutics Presents Ongoing Clinical Trial Poster at San Antonio Breast Cancer Symposium 2020 Virtual Meeting Bolt Biotherapeutics, Inc.